Feasibility of Elder Mistreatment VOICES-CI Screening Tool (VOICES-CI)

August 29, 2023 updated by: Yale University

Feasibility of Elder Mistreatment VOICES Screening Tool for Older Adults With Cognitive Impairment

The aim of this study is to assess the feasibility of the VOICES Elder Abuse Intervention among older adults with cognitive impairment.

Study Overview

Detailed Description

The VOICES Elder Abuse Intervention was developed and refined to promote self-identification and self-disclosure to increase reporting of elder abuse and elder mistreatment at the point-of-care in the Emergency Department (ED) setting. A study (N= 1000) examining the use of VOICES in a busy ED with cognitively intact older adults was completed.

The purpose of this study is to to assess the feasibility (N= 80) of the VOICES screening tool among older adults with cognitive impairment.

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Connecticut
      • New Haven, Connecticut, United States, 06511
        • St. Raphael Emergency Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Provision of signed and dated informed consent form
  2. Stated willingness to comply with all study procedures and availability for the duration of the study
  3. Age 60 or above
  4. Montreal Cognitive Assessment (MoCA) score between 14-25
  5. Not in police custody
  6. Non-full trauma track upon arrival
  7. Able to consent and communicate in English
  8. Agrees and able to use the iPad

Exclusion Criteria:

  1. Subjects who live in nursing homes or other long-term care settings
  2. At the discretion of the clinician, patient will be excluded if they cannot safely undergo the studies required for participation
  3. Subject refusal to participate
  4. Subjects with clear signs of elder mistreatment
  5. Severe hearing and vision impairment
  6. Presenting with acute intoxication
  7. Presenting with active psychotic symptoms
  8. Presenting with COVID-19 diagnosis and/or severe COVID-19 symptoms

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Elder adults in emergency department setting with cognitive impairment
Elder mistreatment in an Emergency Department setting with cognitive impairment.
Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES) screening tool.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Usage
Time Frame: 5-10 minutes directly following VOICES intervention.
Usage will be determined by the number of patients enrolled in the study that complete the VOICES tool. Our target is to enroll 80 older adults (N=80).
5-10 minutes directly following VOICES intervention.
Participation
Time Frame: 5-10 minutes before VOICES intervention use.
Participation will be determined by the number of patients with cognitive impairment enrolled in VOICES. Successful enrollment of 80 older adults (N=80).
5-10 minutes before VOICES intervention use.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability
Time Frame: 5-10 minutes directly following VOICES intervention use.

Participant satisfaction will be measured using post-use satisfaction survey. Responses will be measured via two 5-point Likert scales where generally higher values represent better outcomes:

Scale 1- Satisfaction: Where 1= "Very Dissatisfied", 2= "Dissatisfied", 3= "Neutral", 4= "Satisfied", and 5= "Very Satisfied".

Scale 2- Agreement: Where 1= "Strongly Disagree", 2= "Disagree", 3= "Neutral", 4= "Agree", and and 5= "Strongly Agree".

5-10 minutes directly following VOICES intervention use.
Practicality
Time Frame: Actual time duration is assessed during VOICES use by the computer program (the actual duration of the patient's time using VOICES). Estimation of completed time is completed 5-10 minutes directly following VOICES intervention use.
Practicality will be assessed by observing the ease of VOICES use by patients. To do this, a series of steps will be watched to determine the efficiency of implementation measured by the average time (1) to consent & orient participants to the tool and (2) needed to complete VOICES documented by the Research Assistant; and (3) patients perceived time of VOICES as measured on post-survey. Each of these will be reported as part of the overall outcome.
Actual time duration is assessed during VOICES use by the computer program (the actual duration of the patient's time using VOICES). Estimation of completed time is completed 5-10 minutes directly following VOICES intervention use.
Efficacy of the Brief Negotiation Interview
Time Frame: Measure collected 5-10 minutes directly following VOICES intervention.
To look at how many patients changed their readiness to disclose after completing the Brief Negotiation Interview (BNI)
Measure collected 5-10 minutes directly following VOICES intervention.
Demand
Time Frame: 5-10 minutes directly following VOICES intervention use.
Demand will be assess through examining how likely will VOICES be used by patients. To do this, the size of target population of EM victims in the ED will be measured by the percent who screen positive for EM and the percent who receive the Brief Negotiation Interview (BNI) portion of VOICES.
5-10 minutes directly following VOICES intervention use.
Number of Participants for Which Self-Identification of Elder Mistreatment Impacted Likelihood of Self-Disclosure
Time Frame: Measure collected 5-10 minutes directly following VOICES intervention.

To explore whether self-identification impacts likelihood of self-disclosure for participants who first self-identified with elder mistreatment.

Effect-size estimation measured by change in the percent of patients who disclose.

Measure collected 5-10 minutes directly following VOICES intervention.
Accuracy
Time Frame: Measure collected up to directly following VOICES intervention to 1 week following VOICES intervention.
To understand the accuracy of the VOICES tool, a preliminary evaluation of the accuracy of VOICES as a screening tool in correctly classifying EM cases that were referred to Adult Protective Services (APS). The percent correct classification will be reported.
Measure collected up to directly following VOICES intervention to 1 week following VOICES intervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Fuad Abujarad, PhD,MSc, Yale University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2022

Primary Completion (Actual)

September 1, 2022

Study Completion (Actual)

September 1, 2022

Study Registration Dates

First Submitted

January 11, 2022

First Submitted That Met QC Criteria

January 25, 2022

First Posted (Actual)

January 31, 2022

Study Record Updates

Last Update Posted (Actual)

September 22, 2023

Last Update Submitted That Met QC Criteria

August 29, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2000023799_a
  • 1R01AG060084-01 (U.S. NIH Grant/Contract)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elder Abuse

Clinical Trials on Virtual cOaching in making Informed Choices on Elder Mistreatment Self-Disclosure (VOICES)

3
Subscribe